Periodic Reporting for period 3 - PATRES-MDS (Pathogenesis and treatment of splicing factor mutant myelodysplastic syndromes)

The myelodysplastic syndromes (MDS) are a group of haematological malignancies that affect 5 per 100,000 people each year. The annual incidence of MDS rises with age reaching 30 per 100,000 for those aged 70 years or older. Unfortunately, despite the development of some new...